Keyphrases
Pharmacokinetics
100%
Sotalol
85%
Normal Men
85%
Isosorbide Dinitrate
68%
Sustained-release Formulation
51%
Plasma Parameters
46%
Blocking Agent
42%
Pharmacodynamics
39%
Oral Sustained Release
37%
Oral Administration
36%
Adrenergic Blockers
34%
Beta-blockers
31%
Heart Rate
28%
Systolic Blood Pressure
28%
Healthy Volunteers
26%
Single Oral Dose
25%
Placebo
25%
Normal Volunteers
25%
Finger Plethysmography
21%
Intravenous Administration
21%
Healthy Male Volunteers
20%
Finger Pulse
17%
Quinapril
17%
Parenteral Administration
17%
Chronic Implant
17%
Miniature pig
17%
β-Adrenergic Blocking Agent
17%
Essential Hypertension
17%
Adverse Effects
17%
ECG Intervals
17%
Analgesic Activity
17%
Ointment
17%
Hemodynamic Effects
17%
Double Product
17%
Sleep EEG
17%
Acidic Extraction
17%
Agonist Activity
17%
Clinically Significant
17%
Tachycardia
17%
Oral Dose
17%
Spectrofluorometric
17%
Catheter
17%
Sleep Parameters
17%
Inferior Vena Cava
17%
Angiotensin-converting Enzyme Inhibitor (ACEi)
17%
Hypoxia
17%
Codeine
17%
Onset of Action
17%
Cold Stimulation
17%
Phase I Study
17%
Pharmacology, Toxicology and Pharmaceutical Science
Pharmacokinetics
100%
Sotalol
85%
Isosorbide Dinitrate
68%
Sustained Release
51%
Beta Adrenergic Receptor Blocking Agent
51%
Elimination
43%
Normal Human
42%
Pharmacodynamics
39%
Adrenergic Receptor Blocking Agent
37%
Tablet
22%
Amobarbital
17%
Hypoxia
17%
Adverse Event
17%
Essential Hypertension
17%
Cetamolol
17%
Dipeptidyl Carboxypeptidase Inhibitor
17%
Idebenone
17%
Digoxin
17%
Drug Action
17%
Quinapril
13%
Catecholamine
11%
Metoprolol
10%
Zwitterion
8%
Chloroform
8%
Ethanol
8%
Buffer
8%
Receptor
7%
Pharmacokinetic Parameter
6%
Isoprenaline
6%
Barbiturate
5%
Galenic Formulation
5%
Placebo
5%
Gelatin
5%
Hypertensive Factor
5%
Noradrenalin
5%
Active Metabolite
5%
Angiotensin
5%
1,4 Benzoquinone
5%
Amphetamine
5%
